BSE filing, NSE: DYNPRO. Summary written from the filing by ALFA Finder's alert engine.
Dynemic Products Ltd: key numbers
- Share price
- ₹233.04
- Market cap
- ₹289.6 Cr
- Revenue (annual)
- ₹378.6 Cr
- Net profit (annual)
- ₹19.94 Cr
- P/E (TTM)
- 14.2×Sector 34.1×
- Promoter holding
- 29.42%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dynemic Products Ltd
All →Dynemic Products Board Meeting Date
Dynemic Products has scheduled its Board meeting for 30 October 2026. The agenda includes review of unaudited financial results for the quarter ended 30 September 2026.
Dynemic Products Other Announcement
Dynemic Products Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure complies with SEBI Regulation 31(1)(b).
Dynemic Products Management Change
Dynemic Products Ltd announced the resignation of its Chief Financial Officer, Mr. Ankit Shah, effective from the close of business hours on September 30, 2026.
Dynemic Products Annual General Meeting
Dynemic Products Ltd held its 36th Annual General Meeting on September 28, 2026. Shareholders approved a dividend of Rs. 1.50 per equity share for FY 2025-26.
Dynemic Products Annual General Meeting
Dynemic Products Limited has issued a notice for its 36th Annual General Meeting on September 28, 2026. Key agendas include dividend declaration and related-party transaction approvals.
- Value
- ₹5.00 Cr
Dynemic Products Annual General Meeting
Dynemic Products Limited has issued a notice for its 36th AGM scheduled for September 28, 2026. Key agenda items include a Rs. 1.50 per share dividend declaration.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.